usell.com (PXHI) 10-Q 14 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 14, 2014
Document Information [Line Items]	'	'
Entity Registrant Name	'usell.com, Inc.	'
Entity Central Index Key	'0001271075	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'USEL	'
Entity Common Stock, Shares Outstanding	'	7,528,261
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash and cash equivalents	$3,745,646	$489,166
Accounts receivable, net	129,560	184,718
Other receivables	0	29,257
Prepaid expenses and other current assets	109,897	95,808
Total Current Assets	3,985,103	798,949
Property and equipment, net	6,195	7,289
Intangible assets, net	905,122	806,964
Other assets	25,875	34,520
Total Assets	4,922,295	1,647,722
Current Liabilities:	'	'
Accounts payable	767,458	651,296
Accrued expenses	460,710	327,913
Deferred revenue	173,002	87,313
Derivative liability	0	1,001,385
Total Current Liabilities	1,401,170	2,067,907
Convertible notes payable, net of discount	0	246,128
Total Liabilities	1,401,170	2,314,035
Stockholders' Equity (Deficit):	'	'
Common stock; $0.0001 par value; 650,000,000 shares authorized; 7,572,703 and 4,973,073 shares issued, respectively, and 7,528,261 and 4,907,462 shares outstanding, respectively	753	490
Additional paid in capital	54,177,048	44,087,232
Accumulated deficit	-50,656,806	-44,754,133
Total Stockholders' Equity (Deficit)	3,521,125	-666,313
Total Liabilities and Stockholders' Equity (Deficit)	4,922,295	1,647,722
Series A Convertible Preferred Stock [Member]	'	'
Stockholders' Equity (Deficit):	'	'
Convertible Preferred Stock, Value	10	0
Series B Convertible Preferred Stock [Member]	'	'
Stockholders' Equity (Deficit):	'	'
Convertible Preferred Stock, Value	95	98
Series C Convertible Preferred Stock [Member]	'	'
Stockholders' Equity (Deficit):	'	'
Convertible Preferred Stock, Value	15	0
Series E Convertible Preferred Stock [Member]	'	'
Stockholders' Equity (Deficit):	'	'
Convertible Preferred Stock, Value	$10	$0

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Sep. 30, 2014	Dec. 31, 2013
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	650,000,000	650,000,000
Common stock, shares issued	7,572,703	4,973,073
Common stock, shares outstanding	7,528,261	4,907,462
Series A Convertible Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	325,000	325,000
Preferred stock, shares issued	100,000	0
Preferred stock, shares outstanding	100,000	0
Preferred stock, liquidation value (in dollars)	$300,000	$0
Series B Convertible Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	951,250	976,250
Preferred stock, shares outstanding	951,250	976,250
Preferred stock, liquidation value (in dollars)	$951,250	$976,250
Series C Convertible Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	146,667	146,667
Preferred stock, shares issued	146,667	0
Preferred stock, shares outstanding	146,667	0
Series E Convertible Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	103,232	103,232
Preferred stock, shares issued	103,232	0
Preferred stock, shares outstanding	103,232	0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue	$1,432,388	$1,636,386	$4,147,637	$3,907,124
Costs and Expenses	'	'	'	'
Cost of revenue	164,419	133,244	429,058	304,408
Sales and marketing expenses	1,885,249	1,316,086	4,610,795	3,271,162
General and administrative expenses	1,134,166	900,806	3,448,568	3,792,413
Total operating expenses	3,183,834	2,350,136	8,488,421	7,367,983
Loss from Operations	-1,751,446	-713,750	-4,340,784	-3,460,859
Other (Expense) Income:	'	'	'	'
Interest income	815	391	1,507	1,616
Interest expense	-17	-101,734	-891,312	-102,257
Gain on settlements of accounts payable	0	0	9,038	4,772
Derivative expense - convertible notes payable	0	-28,134	0	-28,134
Change in fair value of derivative liability - embedded conversion feature of Convertible Series A preferred stock	0	0	0	47,876
Change in fair value of derivative liability - convertible notes payable	0	16,916	-681,122	16,916
Total Other (Expense) Income, Net	798	-112,561	-1,561,889	-59,211
Net Loss	($1,750,648)	($826,311)	($5,902,673)	($3,520,070)
Basic and Diluted Loss per Common Share:	'	'	'	'
Net loss per common share - basic and diluted (in dollars per share)	($0.26)	($0.17)	($1)	($0.80)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	6,718,248	4,806,587	5,928,031	4,386,316

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($5,902,673)	($3,520,070)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:	'	'
Depreciation and amortization	403,105	262,481
Provision for (Recovery of) bad debt	8,835	-48,299
Stock based compensation expense	1,098,856	1,818,577
Amortization of debt issue costs into interest expense	8,645	0
Amortization of debt discount into interest expense	873,872	92,343
Lease termination expense	0	9,000
Gain on settlement of accounts payable	-9,038	-4,772
Derivative expense pertaining to convertible notes payable	0	28,134
Change in fair value of derivative liability - embedded conversion feature of convertible Series A preferred stock issuance	0	-47,876
Change in fair value of derivative liability - convertible notes payable	681,122	-16,916
Changes in operating assets and liabilities:	'	'
Accounts receivable	55,158	-15,271
Other receivables	20,422	36,044
Prepaid and other current assets	1,765	-58,750
Accounts payable	125,200	3,175
Accrued expenses	163,789	111,343
Deferred revenues	85,689	35,036
Net Cash and Cash Equivalents Used In Operating Activities	-2,385,253	-1,315,821
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Website development costs	-498,068	-381,589
Cash paid to purchase property and equipment	-2,101	-5,645
Net Cash and Cash Equivalents Used In Investing Activities	-500,169	-387,234
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Proceeds from sale of common stock	6,424,999	0
Proceeds from sale of convertible Series A preferred stock	300,000	0
Proceeds from exercise of warrants	387,500	0
Proceeds from convertible notes payable	0	950,000
Cash paid for debt issue costs	0	-9,090
Cash paid for direct offering costs	-970,597	0
Net Cash and Cash Equivalents Provided By Financing Activities	6,141,902	940,910
Net Increase (Decrease) in Cash and Cash Equivalents	3,256,480	-762,145
Cash and Cash Equivalents - Beginning of Period	489,166	1,604,587
Cash and Cash Equivalents - End of Period	3,745,646	842,442
SUPPLEMENTARY CASH FLOW INFORMATION:	'	'
Cash Paid During the Period for: Interest	0	0
Cash Paid During the Period for: Taxes	0	0
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Derivative liability reclassified to Additional Paid in Capital upon conversion of Convertible Notes Payable	1,682,507	0
Conversion of Convertible Notes Payable and accrued interest to common stock	841,294	0
Common stock issued for services	51,695	23,625
Issuance of Series C preferred stock in exchange for warrants	15	0
Debt discount recorded on convertible notes payable	0	924,125
Series A preferred stock [Member]	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Derivative liability reclassified to Additional Paid in Capital upon conversion of Convertible Notes Payable	0	105,900
Conversion of Series Preferred Stock into Common Stock	0	18
Series B preferred stock [Member]	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Conversion of Series Preferred Stock into Common Stock	3	110
Series D preferred stock [Member]	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Conversion of Series Preferred Stock into Common Stock	0	35
Series E Preferred Stock [Member]	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Conversion of Convertible Notes Payable and accrued interest to common stock	$309,698	$0

Organization_and_Business

Organization and Business	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	Note 1 - Organization and Business
	uSell.com, Inc., through our wholly-owned subsidiaries (collectively, “uSell,” “Company,” “we,” “us,” and/or “our”), is a technology based company focused on creating an online marketplace where sellers can sell small consumer electronics to professional buyers using an ecommerce website-based platform. Through participation in the uSell marketplace, our buyers can acquire high volumes of inventory in a cost effective manner, while minimizing the investment and risk associated with creating and running their own branded advertising campaigns.
	We utilize consumer oriented advertising efforts, such as direct response television commercials, and various forms of Internet advertising to attract sellers to our website. We facilitate transactions by developing technology and logistics systems that seamlessly move product from sellers’ homes to buyers’ warehouses. We also provide our buyers with value added services, such as shipping kit fulfillments, check processing and analytics.
	Reverse Stock Split
	On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (“Reverse Split”). As a result of the Reverse Split, every fifteen shares of our common stock were combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding. All share and per share amounts have been retroactively restated to reflect the Reverse Split. The authorized number of shares of our common stock and the par value remained the same. The Reverse Split did not affect the shares of preferred stock outstanding, however it did affect the number of common stock shares issuable to holders upon conversion.

Liquidity_and_Management_Plans

Liquidity and Management Plans	9 Months Ended
	Sep. 30, 2014
Liquidity Risks and Managements Plans [Abstract]	'
Liquidity Disclosures [Text Block]	'
	Note 2 – Liquidity and Management Plans
	As reflected in the accompanying financial statements, the Company had a net loss of approximately $5,903,000 and net cash and cash equivalents used in operations of approximately $2,385,000 for the nine months ended September 30, 2014. The Company has an accumulated deficit of approximately $50,657,000 at September 30, 2014. The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of debt and equity securities.
	Management believes that the cash balance at September 30, 2014 of approximately $3,746,000, current level of positive working capital of approximately $2,584,000, anticipated cash that will be received from expected future sales, and additional funds through the issuance of debt and equity securities will be sufficient to sustain operations for the next twelve months.
	However, there can be no assurance that the plans and actions proposed by management will be successful, that the Company will generate anticipated revenues from its consumer electronics referrals, or that unforeseen circumstances will not require additional funding sources in the future or effectuate plans to conserve liquidity.

Significant_Accounting_Policie

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	Note 3 - Significant Accounting Policies
	Basis of Presentation
	The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is our opinion, however, that the accompanying unaudited interim condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
	The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the years ended December 31, 2013 and 2012. The financial information as of December 31, 2013 is derived from the audited financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2013. The interim results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014 or for any future interim periods.
	Principles of Consolidation
	The accompanying unaudited interim condensed consolidated financial statements include the accounts of uSell and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited interim condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
	Cash and Cash Equivalents
	All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates fair value. Cash equivalents generally consist of money market accounts.
	We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. At times, our cash may be uninsured or exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.
	Accounts Receivable and Other Receivables
	Accounts receivable and other receivables represent obligations from our buyers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $12,335 and $3,500 at September 30, 2014 and December 31, 2013, respectively.
	Intangible Assets
	Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.
	We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.
	Convertible Instruments
	We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:
		a)	The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,
		b)	The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and
		c)	A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).
	A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.
	For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.
	Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.
	Common Stock Purchase Warrants and Derivative Financial Instruments
	We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:
		a)	Equity if they (i) require physical settlement or net-share settlement, or (ii) give us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or
		b)	Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	Revenue Recognition
	Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.
	Seller Electronics Referrals
	Sellers responding to our advertising campaigns go to our website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of our buyers. We offer this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, we earned up front “lead fees” from buyers when sellers accepted offers on our website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. We recognized revenue upon online acceptance of the buyer’s offer by the seller. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.
	During 2013, our buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.
	Beginning in February 2014, we started a transition of our business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay us a commission only when they pay the seller for a received device and we recognize revenue upon payment to the seller.
	Fulfillment Revenue
	In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by sellers. We act as the agent in these transactions, passing orders booked by our buyers to our fulfillment vendors, who then assemble the kits and mail them directly to the sellers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the sellers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.
	Advertising Revenue
	Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.
	Cost of Revenue
	Our cost of revenue consists primarily of costs to maintain our website, including amortization expense on our technology platform software.
	Advertising
	Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $1,835,000 and $1,276,000 for the three months ended September 30, 2014 and 2013, respectively, and approximately $4,500,000 and $3,167,000 for the nine months ended September 30, 2014 and 2013, respectively.
	Share-Based Payment Arrangements
	We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
	Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense for the three and nine months ended September 30, 2014 and 2013.
	Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
	Net Loss per Share
	Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants) and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.
	The computation of basic and diluted loss per share at September 30, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
				Three and Nine Months Ended
				September 30,
				2014			2013
	Convertible Notes Payable			-			316,667
	Convertible Series A Preferred Stock			100,000			-
	Convertible Series B Preferred Stock			60,415			62,002
	Convertible Series C Preferred Stock			146,667			-
	Convertible Series E Preferred Stock			103,232			-
	Unvested Restricted Stock			54,442			225,667
	Unvested Restricted Stock Units			629,331			-
	Stock Options			594,625			476,516
	Stock Warrants			802,520			542,937
			2,491,232			1,623,789
Legal Proceedings
From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.
Customer Concentrations
The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.
			Percentage of Revenue					Percentage of
			During the Three					Revenue During the
			Months Ended					Nine Months Ended
			September 30,					September 30,
			2014			2013		2014		2013
Buyer A			22	%		5	%	14	%	9	%
Buyer B			5	%		27	%	8	%	27	%
Buyer C			8	%		20	%	8	%	20	%
		Percentage of Accounts
		Receivable at
		September 30,			December 31,
		2014			2013
Buyer A		13	%		1	%
Buyer C		5	%		14	%
Buyer BB		27	%		35	%
Buyer CC		5	%		-
Buyer DD		-			17	%
Recent Accounting Pronouncements
In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU, No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 201-09). ASU 201-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for fiscal years beginning after December 15, 2016 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.
In June 2014, the FASB issued ASU No. 2014-12, “Compensation - Stock Compensation” (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 affects entities that grant their employees share-based payments in which terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments in ASU 2014-12 require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-12 will have on the Company’s consolidated financial statements and disclosures.
In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its financial position or results of operations.
Subsequent events
The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued for potential recognition or disclosure. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Fair_Value

Fair Value	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	Note 4 - Fair Value
	The fair value of our financial assets and liabilities reflects our estimate of amounts that we would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of our assets and liabilities, we seek to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
		Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
		Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
		Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
	The following are the major categories of assets and liabilities measured at fair value on a recurring basis at September 30, 2014 and December 31, 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
		At September 30, 2014					At December 31, 2013
		Assets			Liabilities		Assets		Liabilities
	Level 1
	None	$	-		$	-	$	-	$	-
	Level 2
	None		-			-		-		-
	Level 3
	Derivative liability		-			-		-		1,001,385
		$	-		$	-	$	-	$	1,001,385
	The following table reflects the change in fair value of our derivative liabilities for the nine months ended September 30, 2014:
	Balance at beginning of period		$	1,001,385
	Change in value of derivative liability - convertible notes			681,122
	Reclassification of price protection feature to additional paid in capital - converted notes			-1,682,507
	Balance at end of period		$	-
	We determined the estimated fair value amounts using available market information and appropriate methodologies. However, considerable judgment is required in interpreting market data to develop the estimates of fair value. The estimates presented are not necessarily indicative of the amounts that we could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. We have based these fair value estimates on pertinent information available as of the respective balance sheet dates and have determined that, as of such dates, the carrying value of all financial instruments approximates fair value.

Intangible_Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	Note 5 - Intangible Assets
	Intangible assets consist of the following:
		Capitalized		Website
		Software		Domain		Total
	Gross value at September 30, 2014	$	1,816,044	$	67,752	$	1,883,796
	Accumulated amortization at September 30, 2014		-910,922		-67,752		-978,674
	Net value at September 30, 2014	$	905,122	$	-	$	905,122
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at December 31, 2013	$	806,964	$	-	$	806,964
	Our intangible assets are amortized on a straight-line basis over their estimated useful lives of two to three years. Amortization expense amounted to $146,368 and $116,593 for the three months ended September 30, 2014 and 2013, respectively, and $399,910 and $258,664 for the nine months ended September 30, 2014 and 2013, respectively.
	Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,
	2014 (remaining three months)	$	138,761
	2015		466,793
	2016		208,469
	2017		91,099
		$	905,122

Convertible_Notes

Convertible Notes	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	Note 6 - Convertible Notes
	During the year ended December 31, 2013, we borrowed $1,220,000 and issued convertible notes payable (the “Convertible Notes”) which we used for working capital purposes. The Convertible Notes were convertible at $3.00 per share, after giving effect to the Reverse Split as defined in Note 1, due two years from the date of the investment and bore interest of 5% per annum payable in common stock upon maturity or conversion. The Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Company’s outstanding voting stock was sold or there was a sale of substantially all of the Company’s assets, or (iii) the closing price of the Company’s common stock was more than $4.50 for 10 consecutive trading days. Additionally, investors had price protection on future non-exempted issuances at a price lower than $3.00 per share of common stock or common stock equivalent.
	At the time of the issuances, we determined that the price protection feature on the Convertible Notes constituted a derivative liability and estimated the fair value of such liability to be $1,244,351 using the Black-Scholes option pricing model. We recorded the fair value of the liability of $1,244,351 as a derivative liability since the price protection feature of the Convertible Notes represented a variable conversion feature. Of this amount, we recorded $1,182,856 as a discount to the Convertible Notes and $61,495 as derivative expense.
	During the year ended December 31, 2013, we issued 33,514 shares of our common stock in connection with the conversion of $100,000 of Convertible Notes, along with accrued interest of $541.
	In February 2014, holders of $820,000 Convertible Notes converted their principal, plus accrued interest of $21,294, into 280,427 shares of common stock. In addition, in February 2014, a holder of a $300,000 Convertible Note converted his note, plus accrued interest of $9,698, into 103,232 shares of newly designated Series E Preferred Stock (see Note 7). On the date of conversion, we determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	0.22	%
	Expected dividend yield	0	%
	Expected volatility	239.41	%
	Expected term	1.35 - 1.77 years
	We recorded an expense of $681,122 during the nine months ended September 30, 2014, representing the net change in the fair value of the derivative liability pertaining to the Convertible Notes through the date of conversion and, as the derivative liability is eliminated upon conversion, recorded $1,682,507 as additional paid in capital.
	We evaluated the conversion of the $300,000 Convertible Note into the Series E Preferred Stock using the applicable guidance in ASC 470-20, “Debt with Conversion and Other Options,” whereby if a convertible instrument is converted to equity securities of the debtor pursuant to an inducement offer, the debtor shall recognize an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. No gain or loss was recognized by the Company upon the conversion of the Convertible Notes into the Series E Preferred Stock since the fair value of the securities transferred was determined to be equal to the fair value of the securities issuable pursuant to the original conversion terms.
	The discount of $1,182,856 was being accreted to non-cash interest expense over the contractual term of the Convertible Notes. During the nine months ended September 30, 2014, accretion of the remaining discount amounted to $873,872. Contractual interest expense on the Convertible Notes amounted to $8,745 for the nine months ended September 30, 2014.
	The Company incurred fees associated with the closing of the Convertible Notes of $10,970. These amounts were recorded as other assets and were being amortized to interest expense over the contractual term of the Convertible Notes. During the nine months ended September 30, 2014, accretion of the fees amounted to $8,645.
	At September 30, 2014, all Convertible Notes have been converted and, as such, no balances remain outstanding.

Preferred_Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Preferred Stock [Text Block]	'
	Note 7 - Preferred Stock
	Convertible Series A Preferred Stock
	As of September 30, 2014, we have 100,000 shares of Convertible Series A Preferred Stock, with a par value of $0.0001 per share (“Series A”), outstanding. The Series A has:
		a)	Seniority and a liquidation preference over all classes of common stock, but is subordinate to our Series B Preferred Stock;
		b)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series A is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		c)	A stated liquidation value of $3.00 per share;
		d)	No stated dividends; and
		e)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series A.
	On January 27, 2014, we sold 100,000 shares of Series A for proceeds of $300,000.
	Convertible Series B Preferred Stock
	As of September 30, 2014, we have 951,250 shares of Convertible Series B Preferred Stock, with a par value of $0.0001 per share, (“2010 Series B PS”) outstanding.
	The 2010 Series B PS has:
		(a)	Seniority to all classes of common and preferred stock existing or issued in the future;
		(b)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of 2010 Series B PS is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		(c)	A stated liquidation value of $1.00 per share, and a liquidation preference of the greater of $1 per share, or the amount that would be due if all 2010 Series B PS shares had been converted to common stock immediately prior to the liquidation event;
		(d)	No stated dividends;
		(e)	An option by the holder to convert each share into common shares at a rate of 0.0635 shares of common for each share of 2010 Series B PS;
	On February 4, 2014, a holder of 25,000 shares of our 2010 Series B PS converted his shares into 1,587 shares of common stock.
	Convertible Series C Preferred Stock
	On January 24, 2014, our Board authorized the issuance of up to 146,667 shares of Convertible Series C Preferred Stock (“Series C”), with a par value of $0.0001 per share.  The Series C has:
		a)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series C is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series C.
	On January 27, 2014, we issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	As of September 30, 2014, there are 146,667 shares of Series C outstanding.
	Convertible Series E Preferred Stock
	On March 3, 2014, our Board authorized the issuance of up to 103,232 shares of Convertible Series E Preferred Stock (“Series E”), with a par value of $0.0001 per share.  The Series E has:
		a)	Voting rights and powers equal to the voting rights and powers of our common stock. Each share of Series E is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series E.
	In February 2014, we issued 103,232 shares of Series E upon the conversion of a $300,000 Convertible Note, plus accrued interest of $9,698.
	As of September 30, 2014, there are 103,232 shares of Series E outstanding.

Public_Offering

Public Offering	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders Equity Note Public Offering Disclosure [Text Block]	'
	Note 8 – Public Offering
	On August 15, 2014, we sold an aggregate of 1,550,000 units at $3.00 per unit (“Units”) for gross proceeds of $4,650,000. Each Unit consisted of one share of our common stock and one-half warrant. Each warrant is exercisable for five years and entitles the holder to purchase one share of common stock at an exercise price of $3.20 per share. We estimated that the fair value of the warrant was $1,204,759, using the Black-Scholes option pricing model. The fair value of the warrant was estimated as of the date of grant using the following assumptions: (1) expected volatility of 60.7%, (2) risk-free interest rate of 1.55% and (3) expected life of five years. The Company accounted for the fair value of the warrant as a cost of the offering resulting in a charge directly to stockholders’ equity. Dawson James Securities, Inc. (“Dawson James”), our placement agent for the offering, received a commission of $559,900. In addition, we sold Dawson James, for $100, an option to purchase up to a total of 93,000 Units, exercisable for five years at $3.75 per Unit (or an aggregate exercise price of $348,750). We estimated that the fair value of the unit purchase option was $133,355, using the Black-Scholes option pricing model. The fair value of the unit purchase option was estimated as of the date of grant using the following assumptions: (1) expected volatility of 60.7%, (2) risk-free interest rate of 1.55% and (3) expected life of five years. The Company accounted for the fair value of the unit purchase option, inclusive of the receipt of $100 cash payment, as a cost of the offering resulting in a charge directly to stockholders’ equity. Net proceeds, after the payment of commissions and legal and other expenses of $875,047, amounted to $3,774,953.

Common_Stock

Common Stock	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Stockholders Equity Note Disclosure [Text Block]	'
	Note 9 - Common Stock
	In February and March 2014, we sold an aggregate of 591,666 shares of our common stock, par value $0.0001, in a private placement offering for gross proceeds of $1,774,999. Palladium Capital Advisors, LLC (“Palladium”) acted as our placement agent for the offering, received a commission of $75,000 and was issued 22,083 five-year warrants exercisable at $3.00 per share. The Company estimated that the fair value of warrant was $62,241 using the Black-Scholes option pricing model. The fair value of the warrant granted to Palladium was estimated as of the date of grant using the following assumptions: (1) expected volatility of 58.9%, (2) risk-free interest rate of 1.53% and (3) expected life of five years. The Company accounted for the fair value of the warrant as a cost of the private placement offering resulting in a charge directly to stockholders’ equity. Net proceeds, after the payment of commissions and legal and other expenses of $95,550, amounted to $1,679,449.
	Shares Granted to Directors, Consultants and Employees
	On January 27, 2014, we entered into a six month joint marketing agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a cash fee of $40,000 for the first month of service, $30,000 for the second and third month and $10,000 per month thereafter. Additionally, we issued the consultant 30,000 fully vested shares of common stock, having a fair value of $123,744, based on the quoted closing trading price of our common stock as of the grant date. We recorded $0 and $123,744 as compensation expense pertaining to this grant during the three and nine months ended September 30, 2014, respectively.
	On January 30, 2014, we granted 2,000 fully-vested shares of common stock, having a fair value of $6,056, based on the quoted closing trading price of our common stock as of the grant date, to an advisor for services provided. We recorded $0 and $6,056 as professional fees expense pertaining to this grant during the three and nine months ended September 30, 2014, respectively.
	On April 10, 2014, we entered into agreements with Michael Brauser, Chairman of the Board of Directors of the Company, and Doug Feirstein, a former director of the Company, through which each agreed within 90 days to prematurely exercise 216,666 warrants and 33,333 warrants, respectively, exercisable at $3.00 per share (after giving effect to the reverse stock split), with one-half exercised for cash and the other half exchanged for restricted stock units (“RSUs”). Mr. Brauser exercised and exchanged his warrants in July 2014 by paying $324,999 of cash and receiving 108,333 shares of common stock and 108,333 fully vested RSUs to be delivered on July 18, 2019. Mr. Feirstein exercised and exchanged his warrants in July 2014 by paying $50,000 of cash and receiving 16,667 shares of common stock and 16,666 fully vested RSUs to be delivered on July 18, 2019.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	Note 10 - Stock-Based Compensation
	Stock Option Grants
	During the nine months ended September 30, 2014, we granted 118,332 stock options to employees for future services. These options had a fair value of $173,257, using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	1.19 - 1.43	%
	Expected dividend yield	0	%
	Expected volatility	56.89 - 60.87	%
	Expected term	3.75 - 4.00 years
	The options are exercisable at a weighted average exercise price of $3.46 per share over a five-year term and vest over four years. We recorded $7,809 and $16,156 during the three and nine months ended September 30, 2014 as compensation expense pertaining to these grants.
	Including prior period grants and the above grants, we recorded non-cash compensation expense of $114,142 and $295,961 for the three months ended September 30, 2014 and 2013, respectively, and $445,300 and $1,061,440 for the nine months ended September 30, 2014 and 2013, respectively, pertaining to stock option grants.
	Total unrecognized compensation expense related to unvested stock options at September 30, 2014 amounts to $707,548 and is expected to be recognized over a weighted average period of 2.9 years.
	The following table summarizes our stock option activity for the nine months ended September 30, 2014:
						Weighted
						Average
				Weighted		Remaining
				Average		Contractual
			Number of	Exercise		Life	Aggregate
			Options	Price		(in Years)	Intrinsic Value
	Outstanding - December 31, 2013		557,413	$	4.98	4	$	5,250
	Granted		118,332		3.46
	Exercised		-		-
	Forfeited or Canceled		-81,120		4.36
	Outstanding - September 30, 2014		594,625	$	4.77	3.6	$	-
	Exercisable - September 30, 2014		322,633	$	6.12	3.3	$	-
	The following table summarizes our stock option activity for non-vested options for the nine months ended September 30, 2014:
				Weighted
				Average
			Number of	Grant Date
			Options	Fair Value
	Balance at December 31, 2013		237,040	$	4.45
	Granted		118,332		1.46
	Vested		-72,422		-6.32
	Forfeited or Canceled		-10,958		-3.1
	Balance at September 30, 2014		271,992	$	2.75
	Warrants
	The following summarizes our warrant activity for the nine months ended September 30, 2014:
						Weighted
				Weighted		Average
				Average		Remaining
			Number of	Exercise		Contractual Life	Aggregate
			Warrants	Price		(in Years)	Intrinsic Value
	Outstanding - December 31, 2013		476,269		3.02	3.1	$	-
	Granted		797,083		3.19
	Exercised		-254,165		3
	Cancelled/Forfeited		-216,667		3
	Outstanding - September 30, 2014		802,520	$	3.21	4.8	$	-
	Exercisable - September 30, 2014		802,520	$	3.21	4.8	$	-
	During the nine months ended September 30, 2014, a holder exercised 4,166 warrants for proceeds of $12,500.
	As discussed in Note 9, in February 2014, in connection with the private placement offering of our common stock, we issued Palladium five-year warrants to purchase up to an aggregate of 22,083 shares of our common stock at an exercise price of $3.00 per share.
	As discussed in Note 9, in July 2014, our Chairman exercised and exchanged 216,666 warrants for 108,333 RSUs and 108,333 shares of the Company’s common stock. In addition, a former director of the Company exercised and exchanged 33,333 warrants for 16,666 RSUs and 16,667 shares of the Company’s common stock.
	As discussed in Note 8, in August 2014, in connection with our public offering of Units, we issued five-years warrants to purchase up to an aggregate of 775,000 shares of our commons stock at an exercise price of $3.20 per share.
	Additionally, as discussed in Note 7, we issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	There was no expense pertaining to warrants recorded during the three and nine months ended September 30, 2014 and 2013.
	Restricted Stock Awards
	In June 2013, we entered into a one year investor relations agreement with a third party consultant. Pursuant to the terms of the agreement, we are required to pay a monthly cash fee of $3,000 and issued 18,000 shares of our common stock, with 4,500 shares vesting on a quarterly basis, beginning on the effective date of June 10, 2013. During the three months ended March 31, 2014, the final tranche of 4,500 shares, having a fair value of $21,195, based on the quoted closing price of our common stock as of the grant date, vested. This amount was recorded as a prepaid expense and was amortized over the remaining service term. We recorded $0 and $30,758 as professional fees expense pertaining to this grant during the three and nine months ended September 30, 2014, respectively.
	On August 15, 2014, we renewed the above investor relations agreement with the third party consultant for an additional one-year term, commencing August 15, 2014. Pursuant to the terms of the agreement, we are required to pay a monthly cash fee of $3,000 and issued 20,000 shares of our common stock, with 10,000 shares vesting on August 15, 2014 and 10,000 shares vesting on May 15, 2015. We recorded $30,500 as a prepaid expense relating to the 10,000 shares of vested common stock, based on the quoted closing trading price of our common stock as of the grant date. This amount is being amortized over the remaining service term. We recorded $5,083 as professional fees expense pertaining to this grant during the three and nine months ended September 30, 2014.
	On October 18, 2013, we granted an aggregate of 66,666 shares of restricted common stock to two of our advisors for future services to be provided. The restricted stock vests quarterly over a three year period with the first vesting date being December 31, 2013, subject to continued service on each applicable vesting date. Additionally, the restricted stock will automatically vest under certain circumstances including in the event of a change of control of the Company. During the nine months ended September 30, 2014, 16,668 shares, having a fair value of $61,338, based on the quoted closing trading price of our common stock as of the grant date, vested. Accordingly, we recorded $14,501 and $61,338 as compensation expense pertaining to the vested portion of this grant during the three and nine months ended September 30, 2014, respectively.
	On May 15, 2014, we granted 5,000 shares of fully vested restricted common stock to our Interim Chief Financial Officer for services previously provided. The fair value of the common stock on the date of grant was $4.55 per share, based upon the quoted closing trading price of our common stock on the grant date. The aggregate grant date fair value of the award amounted to $22,750, which we recorded as compensation expense during the nine months ended September 30, 2014.
	On April 11, 2014, we granted 150,000 RSUs each to our Chief Executive Officer and Chief Operating Officer. The RSUs vest annually over a five year period with the first vesting date being April 10, 2015, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock on the date of grant is $4.80 per share, based upon our closing market price on the date of grant. The aggregate grant date fair value of the award amounts to $1,440,000, which is being recognized as compensation expense over the vesting period. We recorded $72,000 and $132,000 of compensation expense during the three and nine months ended September 30, 2014 with respect to this award.
	Effective May 19, 2014, we granted an aggregate of 146,000 RSUs to our independent directors. The RSUs vest annually over a three year period with the first vesting date being May 19, 2015, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock on the date of grant is $4.55 per share, based upon our closing market price on the date of grant. The aggregate grant date fair value of the award amounts to $664,300, which is being recognized as compensation expense over the vesting period. We recorded $55,358 and $83,038 of compensation expense during the three and nine months ended September 30, 2014 with respect to this award.
	As discussed in Note 9, in July 2014, our Chairman exercised and exchanged 216,666 warrants for 108,333 RSUs and 108,333 shares of the Company’s common stock. In addition, a former director of the Company exercised and exchanged 33,333 warrants for 16,666 RSUs and 16,667 shares of the Company’s common stock.
	Including prior period grants and the above grants, we recorded non-cash compensation expense of $172,817 and $102,938 for the three months ended September 30, 2014 and 2013, respectively, and $653,556 and $757,138 for the nine months ended September 30, 2014 and 2013, respectively.
	Total unrecognized compensation expense related to unvested stock awards and unvested restricted stock units at September 30, 2014 amounts to $2,337,298 and is expected to be recognized over a weighted average period of 3.8 years.
	A summary of the restricted stock award activity for the nine months ended September 30, 2014 is as follows:
		Number of
		Shares
Unvested Outstanding at December 31, 2013		248,941
Granted		627,999
Vested		-226,500
Unvested Outstanding at September 30, 2014		650,440

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 11 - Subsequent Events
	In November 2014, our Chairman of the Board resigned and our Board of Directors approved the accelerated vesting of his RSUs. Additionally, Daniel Brauser resigned as the Company’s Chief Executive Officer and was appointed as Executive Chairman of the Board and Nikhil Raman was promoted from the Company’s Chief Operating Officer to Chief Executive Officer.
	In addition, one of our independent directors also resigned in November 2014 and, as a result, his RSUs were forfeited.

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

'

Basis of Accounting, Policy [Policy Text Block]

'

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is our opinion, however, that the accompanying unaudited interim condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013 as filed with the SEC, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the years ended December 31, 2013 and 2012. The financial information as of December 31, 2013 is derived from the audited financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2013. The interim results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results to be expected for the year ending December 31, 2014 or for any future interim periods.

Consolidation, Policy [Policy Text Block]

'

Principles of Consolidation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of uSell and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates, Policy [Policy Text Block]

'

Use of Estimates

The preparation of unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited interim condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

Cash and Cash Equivalents

All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates fair value. Cash equivalents generally consist of money market accounts.

We minimize credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. At times, our cash may be uninsured or exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.

Trade and Other Accounts Receivable, Policy [Policy Text Block]

'

Accounts Receivable and Other Receivables

Accounts receivable and other receivables represent obligations from our buyers. We periodically evaluate the collectability of our accounts receivable and other receivables and consider the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. Our allowance for doubtful accounts was $12,335 and $3,500 at September 30, 2014 and December 31, 2013, respectively.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

'

Intangible Assets

Our intangible assets pertain to capitalized software costs and our website domain address. We capitalize costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.

We periodically review the carrying values of our long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and record an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, we test such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

Debt, Policy [Policy Text Block]

'

Convertible Instruments

We review all of our convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:

a)

The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,

b)

The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and

c)

A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).

A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, we may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.

For convertible instruments that we have determined should not be bifurcated from their host instruments, we record discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, we record deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.

Finally, if necessary, we will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.

Common Stock Purchase Warrants And Derivative Financial Instruments [Policy Text Block]

'

Common Stock Purchase Warrants and Derivative Financial Instruments

We review any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classify them on our balance sheet as:

a)

Equity if they (i) require physical settlement or net-share settlement, or (ii) give us a choice of net-cash settlement or settlement in our own shares (physical settlement or net-share settlement), or

b)

Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside our control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).

We assess classification of our common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.

Revenue Recognition, Policy [Policy Text Block]

'

Revenue Recognition

Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.

Seller Electronics Referrals

Sellers responding to our advertising campaigns go to our website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of our buyers. We offer this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, we earned up front “lead fees” from buyers when sellers accepted offers on our website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. We recognized revenue upon online acceptance of the buyer’s offer by the seller. We record payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.

During 2013, our buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.

Beginning in February 2014, we started a transition of our business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay us a commission only when they pay the seller for a received device and we recognize revenue upon payment to the seller.

Fulfillment Revenue

In December 2012, we began to offer fulfillment services on behalf of our buyers for the items sold by sellers. We act as the agent in these transactions, passing orders booked by our buyers to our fulfillment vendors, who then assemble the kits and mail them directly to the sellers. We earn a standard fee from our buyers and recognize revenue upon shipment of the kits to the sellers. We evaluated the presentation of revenue on a gross versus net basis and determined that since we perform as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.

Advertising Revenue

Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, our advertisers pay us on a cost per click, or CPC basis, which means advertisers pay us only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay us based on the number of times their advertisements appear on our websites or mobile applications.

Cost of Sales, Policy [Policy Text Block]

'

Cost of Revenue

Our cost of revenue consists primarily of costs to maintain our website, including amortization expense on our technology platform software.

Advertising Costs, Policy [Policy Text Block]

'

Advertising

Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $1,835,000 and $1,276,000 for the three months ended September 30, 2014 and 2013, respectively, and approximately $4,500,000 and $3,167,000 for the nine months ended September 30, 2014 and 2013, respectively.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

Share-Based Payment Arrangements

We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.

Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense for the three and nine months ended September 30, 2014 and 2013.

Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.

Earnings Per Share, Policy [Policy Text Block]

'

Net Loss per Share

Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants) and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.

The computation of basic and diluted loss per share at September 30, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

Three and Nine Months Ended

September 30,

2014

2013

Convertible Notes Payable

-

316,667

Convertible Series A Preferred Stock

100,000

-

Convertible Series B Preferred Stock

60,415

62,002

Convertible Series C Preferred Stock

146,667

-

Convertible Series E Preferred Stock

103,232

-

Unvested Restricted Stock

54,442

225,667

Unvested Restricted Stock Units

629,331

-

Stock Options

594,625

476,516

Stock Warrants

802,520

542,937

2,491,232

1,623,789

Commitments and Contingencies, Policy [Policy Text Block]

'

Legal Proceedings

From time to time, we are a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, we are not aware of any proceeding, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

'

Customer Concentrations

The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.

Percentage of Revenue

Percentage of

During the Three

Revenue During the

Months Ended

Nine Months Ended

September 30,

September 30,

2014

2013

2014

2013

Buyer A

22

%

5

%

14

%

9

%

Buyer B

5

%

27

%

8

%

27

%

Buyer C

8

%

20

%

8

%

20

%

Percentage of Accounts

Receivable at

September 30,

December 31,

2014

2013

Buyer A

13

%

1

%

Buyer C

5

%

14

%

Buyer BB

27

%

35

%

Buyer CC

5

%

-

Buyer DD

-

17

%

New Accounting Pronouncements, Policy [Policy Text Block]

'

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU, No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 201-09). ASU 201-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for fiscal years beginning after December 15, 2016 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.

In June 2014, the FASB issued ASU No. 2014-12, “Compensation - Stock Compensation” (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 affects entities that grant their employees share-based payments in which terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments in ASU 2014-12 require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-12 will have on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its financial position or results of operations.

Subsequent Events, Policy [Policy Text Block]

'

Subsequent events

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued for potential recognition or disclosure. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
	The computation of basic and diluted loss per share at September 30, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
			Three and Nine Months Ended
			September 30,
			2014			2013
	Convertible Notes Payable		-			316,667
	Convertible Series A Preferred Stock		100,000			-
	Convertible Series B Preferred Stock		60,415			62,002
	Convertible Series C Preferred Stock		146,667			-
	Convertible Series E Preferred Stock		103,232			-
	Unvested Restricted Stock		54,442			225,667
	Unvested Restricted Stock Units		629,331			-
	Stock Options		594,625			476,516
	Stock Warrants		802,520			542,937
			2,491,232			1,623,789
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	'
	The following table shows significant concentrations in our revenues and accounts receivable for the periods indicated.
			Percentage of Revenue					Percentage of
			During the Three					Revenue During the
			Months Ended					Nine Months Ended
			September 30,					September 30,
			2014			2013		2014		2013
	Buyer A		22	%		5	%	14	%	9	%
	Buyer B		5	%		27	%	8	%	27	%
	Buyer C		8	%		20	%	8	%	20	%
		Percentage of Accounts
		Receivable at
		September 30,			December 31,
		2014			2013
	Buyer A	13	%		1	%
	Buyer C	5	%		14	%
	Buyer BB	27	%		35	%
	Buyer CC	5	%		-
	Buyer DD	-			17	%

Fair_Value_Tables

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]	'
	The following are the major categories of assets and liabilities measured at fair value on a recurring basis at September 30, 2014 and December 31, 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
		At September 30, 2014					At December 31, 2013
		Assets			Liabilities		Assets		Liabilities
	Level 1
	None	$	-		$	-	$	-	$	-
	Level 2
	None		-			-		-		-
	Level 3
	Derivative liability		-			-		-		1,001,385
		$	-		$	-	$	-	$	1,001,385
Fair Value, by Balance Sheet Grouping [Table Text Block]	'
	The following table reflects the change in fair value of our derivative liabilities for the nine months ended September 30, 2014:
	Balance at beginning of period		$	1,001,385
	Change in value of derivative liability - convertible notes			681,122
	Reclassification of price protection feature to additional paid in capital - converted notes			-1,682,507
	Balance at end of period		$	-

Intangible_Assets_Tables

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
	Intangible assets consist of the following:
		Capitalized		Website
		Software		Domain		Total
	Gross value at September 30, 2014	$	1,816,044	$	67,752	$	1,883,796
	Accumulated amortization at September 30, 2014		-910,922		-67,752		-978,674
	Net value at September 30, 2014	$	905,122	$	-	$	905,122
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at December 31, 2013	$	806,964	$	-	$	806,964
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	'
	Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,
	2014 (remaining three months)	$	138,761
	2015		466,793
	2016		208,469
	2017		91,099
		$	905,122

Convertible_Notes_Tables

Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	'
	On the date of conversion, we determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	0.22	%
	Expected dividend yield	0	%
	Expected volatility	239.41	%
	Expected term	1.35 - 1.77 years

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
	These options had a fair value of $173,257, using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	1.19 - 1.43	%
	Expected dividend yield	0	%
	Expected volatility	56.89 - 60.87	%
	Expected term	3.75 - 4.00 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes our stock option activity for the nine months ended September 30, 2014:
						Weighted
						Average
				Weighted		Remaining
				Average		Contractual
			Number of	Exercise		Life	Aggregate
			Options	Price		(in Years)	Intrinsic Value
	Outstanding - December 31, 2013		557,413	$	4.98	4	$	5,250
	Granted		118,332		3.46
	Exercised		-		-
	Forfeited or Canceled		-81,120		4.36
	Outstanding - September 30, 2014		594,625	$	4.77	3.6	$	-
	Exercisable - September 30, 2014		322,633	$	6.12	3.3	$	-
Schedule of Nonvested Share Activity [Table Text Block]	'
	The following table summarizes our stock option activity for non-vested options for the nine months ended September 30, 2014:
				Weighted
				Average
			Number of	Grant Date
			Options	Fair Value
	Balance at December 31, 2013		237,040	$	4.45
	Granted		118,332		1.46
	Vested		-72,422		-6.32
	Forfeited or Canceled		-10,958		-3.1
	Balance at September 30, 2014		271,992	$	2.75
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
	The following summarizes our warrant activity for the nine months ended September 30, 2014:
						Weighted
				Weighted		Average
				Average		Remaining
			Number of	Exercise		Contractual Life	Aggregate
			Warrants	Price		(in Years)	Intrinsic Value
	Outstanding - December 31, 2013		476,269		3.02	3.1	$	-
	Granted		797,083		3.19
	Exercised		-254,165		3
	Cancelled/Forfeited		-216,667		3
	Outstanding - September 30, 2014		802,520	$	3.21	4.8	$	-
	Exercisable - September 30, 2014		802,520	$	3.21	4.8	$	-
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
	A summary of the restricted stock award activity for the nine months ended September 30, 2014 is as follows:
			Number of
			Shares
	Unvested Outstanding at December 31, 2013		248,941
	Granted		627,999
	Vested		-226,500
	Unvested Outstanding at September 30, 2014		650,440

Organization_and_Business_Deta

Organization and Business (Details Textual)	9 Months Ended
	Sep. 30, 2014	Jan. 21, 2014	Dec. 31, 2013
Organization and Business [Line Items]	'	'	'
Stockholders Equity, Reverse Stock Split	'On January 21, 2014, we effected a 1-for-15 reverse stock split of our common stock (Reverse Split). As a result of the Reverse Split, every fifteen shares of our common stock were combined into one share of common stock. Immediately after the January 21, 2014 effective date, we had 4,907,462 shares of common stock outstanding.	'	'
Common Stock, Shares, Outstanding	7,528,261	4,907,462	4,907,462

Liquidity_and_Management_Plans1

Liquidity and Management Plans (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Going Concern [Line Items]	'	'	'	'	'	'
Net Loss	($1,750,648)	($826,311)	($5,902,673)	($3,520,070)	'	'
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	'	'	-2,385,253	-1,315,821	'	'
Accumulated deficit	-50,656,806	'	-50,656,806	'	-44,754,133	'
Working Capital	2,584,000	'	2,584,000	'	'	'
Cash and Cash Equivalents, at Carrying Value, Total	$3,745,646	$842,442	$3,745,646	$842,442	$489,166	$1,604,587

Significant_Accounting_Policie3

Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,491,232	1,623,789
Convertible Notes Payable [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	316,667
Convertible Series A Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	100,000	0
Convertible Series B Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	60,415	62,002
Convertible Series C Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	146,667	0
Convertible Series E Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	103,232	0
Unvested Restricted Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	54,442	225,667
Unvested Restricted Stock Units [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	629,331	0
Stock Options [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	594,625	476,516
Stock Warrants [member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	802,520	542,937

Significant_Accounting_Policie4

Significant Accounting Policies (Details 1)

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Buyer A [Member]

Buyer A [Member]

Buyer A [Member]

Buyer A [Member]

Buyer A [Member]

Buyer A [Member]

Buyer B [Member]

Buyer B [Member]

Buyer B [Member]

Buyer B [Member]

Buyer C [Member]

Buyer C [Member]

Buyer C [Member]

Buyer C [Member]

Buyer C [Member]

Buyer C [Member]

Buyer BB [Member]

Buyer BB [Member]

Buyer CC [Member]

Buyer CC [Member]

Buyer DD [Member]

Buyer DD [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Sales Revenue, Net [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Concentration Risk [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Concentration Risk, Percentage

22.00%

5.00%

14.00%

9.00%

13.00%

1.00%

5.00%

27.00%

8.00%

27.00%

8.00%

20.00%

8.00%

20.00%

5.00%

14.00%

27.00%

35.00%

5.00%

0.00%

0.00%

17.00%

Significant_Accounting_Policie5

Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Significant Accounting Policies [Line Items]	'	'	'	'	'
Allowance for Doubtful Accounts Receivable	$12,335	'	$12,335	'	$3,500
Advertising Expense	$1,835,000	$1,276,000	$4,500,000	$3,167,000	'

Fair_Value_Details

Fair Value (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'
Derivative Asset, Fair Value, Net	$0	$0
Derivative Liability, Fair Value, Net	0	1,001,385
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	0	0
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]	'	'
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	$0	$1,001,385

Fair_Value_Details_1

Fair Value (Details 1) (USD $)	9 Months Ended
	Sep. 30, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Balance at beginning of period	$1,001,385
Change in value of derivative liability - convertible notes	681,122
Reclassification of price protection feature to additional paid in capital - converted notes	-1,682,507
Balance at end of period	$0

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Gross value	$1,883,796	$1,385,728
Accumulated amortization	-978,674	-578,764
Net value	905,122	806,964
Capitalized Software [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross value	1,816,044	1,317,976
Accumulated amortization	-910,922	-511,012
Net value	905,122	806,964
Website Domain [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross value	67,752	67,752
Accumulated amortization	-67,752	-67,752
Net value	$0	$0

Intangible_Assets_Details_1

Intangible Assets (Details 1) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Years ending December 31,	'	'
2014 (remaining three months)	$138,761	'
2015	466,793	'
2016	208,469	'
2017	91,099	'
Net value	$905,122	$806,964

Intangible_Assets_Details_Text

Intangible Assets (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Assets, Amortization Method	'	'	'straight-line basis	'
Amortization of Intangible Assets	$146,368	$116,593	$399,910	$258,664
Minimum [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'2 years	'
Maximum [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'3 years	'

Convertible_Notes_Details

Convertible Notes (Details) (Convertible Notes Payable [Member])	9 Months Ended
	Sep. 30, 2014
Debt Conversion [Line Items]	'
Risk-free interest rate	0.22%
Expected dividend yield	0.00%
Expected volatility	239.41%
Maximum [Member]	'
Debt Conversion [Line Items]	'
Expected term	'1 year 9 months 7 days
Minimum [Member]	'
Debt Conversion [Line Items]	'
Expected term	'1 year 4 months 6 days

Convertible_Notes_Details_Text

Convertible Notes (Details Textual) (USD $)	3 Months Ended		9 Months Ended			9 Months Ended	12 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2013
						Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Convertible Notes Payable [Member]
								Series E Preferred Stock [Member]	Common Stock [Member]	Maximum [Member]	Minimum [Member]
Debt Conversion [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Proceeds from Notes Payable	'	'	'	'	'	'	$1,220,000	'	'	'	'
Accounts Payable, Interest-bearing, Interest Rate	'	'	'	'	'	'	5.00%	'	'	'	'
Common Stock, Par or Stated Value Per Share	$0.00	'	$0.00	'	$0.00	'	'	'	'	$3.75	$3
Derivative Liability, Fair Value, Gross Liability	'	'	'	'	'	1,682,507	1,244,351	'	'	'	'
Financial Services Costs, Total	'	'	'	'	'	'	61,495	'	'	'	'
Derivative, Gain (Loss) on Derivative, Net, Total	0	16,916	-681,122	16,916	'	681,122	'	'	'	'	'
Non Cash Interest Expense	'	'	'	'	'	1,182,856	'	'	'	'	'
Accretion of Discount	'	'	'	'	'	873,872	'	'	'	'	'
Interest Expense, Total	17	101,734	891,312	102,257	'	8,745	'	'	'	'	'
Notes Payable Fee	'	'	'	'	'	10,970	'	'	'	'	'
Accretion Expense	'	'	'	'	'	8,645	'	'	'	'	'
Debt Conversion, Converted Instrument, Shares Issued	'	'	'	'	'	'	33,514	103,232	280,427	'	'
Debt Conversion, Original Debt, Amount	'	'	'	'	'	'	100,000	300,000	820,000	'	'
Interest Payable	'	'	'	'	'	'	541	9,698	21,294	'	'
Debt Instrument, Convertible, Conversion Price	'	'	'	'	'	'	$3	'	'	'	'
Debt Instrument, Unamortized Discount	'	'	'	'	'	'	1,182,856	'	'	'	'
Common Stock, To be Issued, Value	'	'	'	'	'	'	$1,000,000	'	'	'	'
Debt Instrument, Convertible, Terms of Conversion Feature	'	'	'	'	'	'	'The Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Companys outstanding voting stock was sold or there was a sale of substantially all of the Companys assets, or (iii) the closing price of the Companys common stock was more than $4.50 for 10 consecutive trading days.	'	'	'	'

Preferred_Stock_Details_Textua

Preferred Stock (Details Textual) (USD $)

12 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

Dec. 31, 2013

Mar. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Convertible Notes Payable [Member]

Common Stock [Member]

Warrant [Member]

Series B Preferred Stock 2010 [Member]

Series B Preferred Stock 2010 [Member]

Series A Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series E Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series E Convertible Preferred Stock [Member]

Series E Convertible Preferred Stock [Member]

Common Stock [Member]

Convertible Notes Payable [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

'

'

4,000,000

4,000,000

'

146,667

146,667

325,000

325,000

103,232

103,232

Preferred stock, par value (in dollars per share)

'

'

'

'

'

'

$0.00

$0.00

'

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

Preferred Stock, Liquidation Preference Per Share

'

'

'

'

'

'

$1

'

'

'

'

$3

'

'

'

Preferred stock, shares outstanding

'

'

'

'

'

'

951,250

976,250

'

146,667

0

100,000

0

103,232

0

Number Of Shares In Each Share On Conversion

'

'

'

0.0635

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Preferred Stock and Preference Stock

'

'

'

'

'

$300,000

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

33,514

'

'

'

'

'

'

'

103,232

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

591,666

'

'

'

100,000

'

'

'

'

'

'

'

'

'

Interest Payable

541

'

'

'

'

'

'

'

9,698

'

'

'

'

'

'

Conversion of Stock, Shares Issued

'

'

'

'

1,587

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

$100,000

'

'

'

'

'

'

'

$300,000

'

'

'

'

'

'

Stock Issued During Period, Shares, Conversion of Convertible Securities

'

'

216,667

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period

'

'

'

'

'

'

'

'

'

146,667

'

'

'

'

'

Public_Offering_Details_Textua

Public Offering (Details Textual) (USD $)	0 Months Ended	9 Months Ended
	Aug. 15, 2014	Sep. 30, 2014	Sep. 30, 2013
Proceeds from Issuance or Sale of Equity	$3,774,953	'	'
Payments of Stock Issuance Costs	100	970,597	0
Legal Fees	875,047	'	'
Dawson James Securities, Inc. [Member]	'	'	'
Warrant Fair Value	133,355	'	'
Aggregate Exercise Price of Warrant	348,750	'	'
Stock Issued During Period, Shares, New Issues	93,000	'	'
Shares Issued, Price Per Share	$3.75	'	'
Proceeds from Issuance or Sale of Equity	100	'	'
Fair Value Assumptions, Expected Volatility Rate	60.70%	'	'
Fees and Commissions, Other	559,900	'	'
Warrant Exercisable Term	'5 years	'	'
Risk-Free Interest Rate	1.55%	'	'
Unit [Member]	'	'	'
Warrant Fair Value	1,204,759	'	'
Stock Issued During Period, Shares, New Issues	1,550,000	'	'
Shares Issued, Price Per Share	$3	'	'
Proceeds from Issuance or Sale of Equity	$4,650,000	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	$3.20	'	'
Fair Value Assumptions, Expected Volatility Rate	60.70%	'	'
Warrant Exercisable Term	'5 years	'	'
Risk-Free Interest Rate	1.55%	'	'

Common_Stock_Details_Textual

Common Stock (Details Textual) (USD $)

0 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

Aug. 15, 2014

Sep. 30, 2014

Sep. 30, 2013

Apr. 10, 2014

Apr. 10, 2014

Jan. 27, 2014

Jan. 27, 2014

Jan. 27, 2014

Jan. 27, 2014

Jan. 27, 2014

Sep. 30, 2014

Sep. 30, 2014

Jan. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Apr. 10, 2014

Apr. 10, 2014

Mar. 31, 2014

Apr. 10, 2014

Mar. 31, 2014

Apr. 10, 2014

Mar. 31, 2014

Board of Directors Chairman [Member]

Board of Directors Chairman [Member]

First Month of Service [Member]

Second Month of Service [Member]

Third Month of Service [Member]

Four and Thereafter Months of Service [Member]

Consultant [Member]

Consultant [Member]

Consultant [Member]

Consultant Advisor [Member]

Consultant Advisor [Member]

Consultant Advisor [Member]

Director [Member]

Director [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Warrant [Member]

Restricted Stock Units (RSUs) [Member]

Joint Marketing Agreement [Member]

Joint Marketing Agreement [Member]

Joint Marketing Agreement [Member]

Joint Marketing Agreement [Member]

Restricted Stock Units (RSUs) [Member]

Board of Directors Chairman [Member]

Private Placement [Member]

Director [Member]

Palladium Capital Advisors, LLC [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exercisable Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

Stock Issued During Period, Shares, New Issues

'

'

'

'

108,333

'

'

'

'

'

'

'

'

'

'

'

16,666

591,666

108,333

'

16,667

22,083

Proceeds from Issuance of Private Placement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,774,999

'

'

Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

58.90%

Risk-free interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.53%

Proceeds from Issuance of Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,679,449

Expected Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

30,000

'

'

2,000

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Issued for Services

'

'

'

'

'

'

'

'

'

123,744

'

'

6,056

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense

'

'

'

'

'

'

'

'

'

'

0

123,744

'

'

'

'

'

'

'

'

'

'

Professional Fees

'

'

'

'

'

40,000

30,000

30,000

10,000

'

'

'

'

0

6,056

'

'

'

'

'

'

'

Payments of Stock Issuance Costs

100

970,597

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75,000

'

95,550

Shares Issued, Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

$3

Stock Issued During Period, Value, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

62,241

Warrants Issued During Period Exercise Price Of Warrants1

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

Proceeds from Warrant Exercises

'

$387,500

$0

$324,999

'

'

'

'

'

'

'

'

'

'

'

$50,000

'

'

'

'

'

'

Warrant Issued During Period, Number of Warrants

'

'

'

216,666

'

'

'

'

'

'

'

'

'

'

'

33,333

'

'

'

'

'

'

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (Employee Stock Option [Member])	9 Months Ended
	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividend yield	0.00%
Maximum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate	1.43%
Expected volatility	60.87%
Expected term (in years)	'4 years
Minimum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate	1.19%
Expected volatility	56.89%
Expected term (in years)	'3 years 9 months

StockBased_Compensation_Detail1

Stock-Based Compensation (Details 1) (Employee Stock Option [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Employee Stock Option [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Options, Outstanding - December 31, 2013	557,413	'
Number of Options, Granted	118,332	'
Number of Options, Exercised	0	'
Number of Options, Forfeited or Cancelled	-81,120	'
Number of Options, Outstanding - September 30, 2014	594,625	557,413
Number of Options, Exercisable - September 30, 2014	322,633	'
Weighted Average Exercise Price, Outstanding - December 31, 2013 (in dollars per share)	$4.98	'
Weighted Average Exercise Price, Granted (in dollars per share)	$3.46	'
Weighted Average Exercise Price, Exercised (in dollars per share)	$0	'
Weighted Average Exercise Price, Cancelled/Forfeited (in dollars per share)	$4.36	'
Weighted Average Exercise Price, Outstanding - September 30, 2014 (in dollars per share)	$4.77	$4.98
Weighted Average Exercise Price, Exercisable - September 30, 2014 (in dollars per share)	$6.12	'
Weighted Average Remaining Contractual Life, Outstanding (in years)	'3 years 7 months 6 days	'4 years
Weighted Average Remaining Contractual Life, Exercisable - September 30, 2014 (in years)	'3 years 3 months 18 days	'
Aggregate Intrinsic Value, Options Outstanding (in dollars)	$0	$5,250
Aggregate Intrinsic Value, Options Exercisable - September 30, 2014 (in dollars)	$0	'

StockBased_Compensation_Detail2

Stock-Based Compensation (Details 2) (Employee Stock Option [Member], USD $)	9 Months Ended
	Sep. 30, 2014
Employee Stock Option [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Options, Beginning Balance at December 31, 2013	237,040
Number of Options, Granted	118,332
Number of Options, Vested	-72,422
Number of Options, Forfeited or Canceled	-10,958
Number of Options, Ending Balance at September 30, 2014	271,992
Weighted Average Grant Date Fair Value, Balance at December 31, 2013 (in dollars per share)	$4.45
Weighted Average Grant Date Fair Value, Granted (in dollars per share)	$1.46
Weighted Average Grant Date Fair Value, Vested (in dollars per share)	($6.32)
Weighted Average Grant Date Fair Value, Forfeited or Canceled (in dollars per share)	($3.10)
Weighted Average Grant Date Fair Value, Balance at September 30, 2014 (in dollars per share)	$2.75

StockBased_Compensation_Detail3

Stock-Based Compensation (Details 3) (Warrant [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Warrant [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of Warrants, Outstanding - December 31, 2013	476,269	'
Number of Warrants, Granted	797,083	'
Number of Warrants, Exercised	-254,165	'
Number of Warrants, Cancelled / Forfeited	-216,667	'
Number of Warrants, Outstanding - September 30, 2014	802,520	476,269
Number of Warrants, Exercisable - September 30, 2014	802,520	'
Weighted Average Exercise Price, Outstanding - December 31, 2013 (in dollars per share)	$3.02	'
Weighted Average Exercise Price, Granted (in dollars per share)	$3.19	'
Weighted Average Exercise Price, Exercised (in dollars per share)	$3	'
Weighted Average Exercise Price, Cancelled/Forfeited (in dollars per share)	$3	'
Weighted Average Exercise Price, Outstanding - September 30, 2014 (in dollars per share)	$3.21	$3.02
Weighted Average Exercise Price, Exercisable - September 30, 2014 (in dollars per share)	$3.21	'
Weighted Average Remaining Contractual Life, Outstanding (in years)	'4 years 9 months 18 days	'3 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable - September 30, 2014 (in years)	'4 years 9 months 18 days	'
Aggregate Intrinsic Value, Options Outstanding (in dollars)	$0	$0
Aggregate Intrinsic Value, Exercisable - September 30, 2014 (in dollars)	$0	'

StockBased_Compensation_Detail4

Stock-Based Compensation (Details 4) (Restricted Stock [Member])	9 Months Ended
	Sep. 30, 2014
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Options, Beginning Balance at December 31, 2013	248,941
Number of Options, Granted	627,999
Number of Options, Vested	-226,500
Number of Options, Ending Balance at September 30, 2014	650,440

StockBased_Compensation_Detail5

Stock-Based Compensation (Details Textual) (USD $)

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Aug. 31, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Apr. 11, 2014

Apr. 11, 2014

Sep. 30, 2014

Sep. 30, 2014

19-May-14

19-May-14

Sep. 30, 2014

Sep. 30, 2014

15-May-14

Sep. 30, 2014

Apr. 10, 2014

Apr. 10, 2014

Apr. 10, 2014

Sep. 30, 2014

Mar. 31, 2014

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Apr. 10, 2014

Apr. 10, 2014

Apr. 10, 2014

Sep. 30, 2014

Sep. 30, 2014

15-May-15

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Oct. 18, 2013

IPO [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Warrant [Member]

Common Stock [Member]

Series C Convertible Preferred Stock [Member]

Chief Executive and Operating Officer [Member]

Chief Executive and Operating Officer [Member]

Chief Executive and Operating Officer [Member]

Chief Executive and Operating Officer [Member]

Independent Director [Member]

Independent Director [Member]

Independent Director [Member]

Independent Director [Member]

Chief Financial Officer [Member]

Chief Financial Officer [Member]

Board of Directors Chairman [Member]

Board of Directors Chairman [Member]

Board of Directors Chairman [Member]

Third Party Consultant One [Member]

Third Party Consultant One [Member]

Third Party Consultant One [Member]

Third Party Consultant One [Member]

Palladium Capital Advisors, LLC [Member]

Director [Member]

Director [Member]

Director [Member]

Third Party Consultant Two [Member]

Third Party Consultant Two [Member]

Third Party Consultant Two [Member]

Warrant Holder [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member]

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock Units (RSUs) [Member]

Common Stock [Member]

Warrant [Member]

Restricted Stock Units (RSUs) [Member]

Common Stock [Member]

Subsequent Event [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Options, Granted

'

'

'

'

'

627,999

'

'

'

'

'

150,000

'

'

'

146,000

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$7,809

'

$16,156

'

'

'

Share-based Compensation, Total

1,098,856

1,818,577

'

172,817

102,938

653,556

757,138

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

114,142

295,961

445,300

1,061,440

'

'

Payments for Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

'

'

'

'

3,000

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,000

'

'

'

'

'

20,000

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,500

'

4,500

'

'

'

'

'

10,000

10,000

'

'

'

'

'

16,668

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

21,195

'

'

'

'

'

'

'

'

30,500

'

'

'

'

'

61,338

'

Professional Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

30,758

'

'

'

'

'

5,083

5,083

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

66,666

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total

'

'

'

2,337,298

'

2,337,298

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'2 years 10 months 24 days

'

'

'

'

'3 years 9 months 18 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Stock or Unit Expense

'

'

'

14,501

'

61,338

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

173,257

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

'

'

'

'

'

'

'

'

'

'

'

$4.80

'

'

'

$4.55

'

'

$4.55

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

'

'

'

'

'

'

'

'

'

'

'

'

72,000

132,000

'

'

55,358

83,038

'

22,750

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

'

'

'

'

'

'

'

'

'

'

'The RSUs vest annually over a five year period with the first vesting date being April 10, 2015, subject to continued service on each applicable vesting date.

'

'

'

'The RSUs vest annually over a three year period with the first vesting date being May 19, 2015, subject to continued service on each applicable vesting date.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

'

'

'

'

'

'

'

'

'

'

'

1,440,000

'

'

'

664,300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

591,666

'

'

'

'

'

'

'

'

'

'

'

'

108,333

108,333

'

'

'

'

22,083

'

16,666

16,667

'

'

'

'

'

'

'

'

'

'

Shares Issued, Price Per Share

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Warrant Exercises

387,500

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

324,999

'

'

'

'

'

'

'

50,000

'

'

'

'

'

12,500

'

'

'

'

'

'

Warrants Issued During Period Exercise Price Of Warrants

'

'

$3.20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Exercisable Term

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period

'

'

'

'

'

'

'

'

'

146,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

81,120

'

'

'

Warrant Issued During Period, Number of Warrants

'

'

775,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

216,666

'

'

'

'

'

'

'

33,333

'

'

'

'

'

4,166

'

'

'

'

'

'

Stock Issued During Period, Shares, Conversion of Convertible Securities

'

'

'

'

'

'

'

216,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

$707,548

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'